Stay updated on Entinostat + Pembrolizumab in Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previous study content with a generic error page. This indicates that access to the NCT03179930 study record is blocked, with the error text visible on the page.
    Difference
    18%
    Check dated 2026-09-20T15:46:12.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page's revision label in the footer updated from v3.6.5 to v3.6.6, signaling a newer build of the ClinicalTrials.gov page.
    Difference
    0.1%
    Check dated 2026-08-29T23:58:18.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The bottom of the page shows a revision stamp updated from v3.6.4 to v3.6.5, indicating a minor template or deployment update. This appears to be a routine system update rather than a change to study information.
    Difference
    0.1%
    Check dated 2026-08-08T22:54:13.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page now shows a new revision tag (v3.6.4) and additional date entries, replacing the prior revision tag (v3.6.3). This indicates a maintenance/update to the page rather than changes to the study data.
    Difference
    0.4%
    Check dated 2026-07-25T12:35:48.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The revision label on the page now shows v3.6.3, replacing the prior v3.6.2. This indicates a new revision of the study record.
    Difference
    0.1%
    Check dated 2026-07-03T23:23:29.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The page now displays an updated revision label, 'Revision: v3.6.2', replacing the previous 'Revision: v3.6.0'. This indicates a routine platform version update without changes to study details or navigation.
    Difference
    0.1%
    Check dated 2026-06-26T23:48:30.000Z thumbnail image

Stay in the know with updates to Entinostat + Pembrolizumab in Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page.